| pubmed-article:21203859 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21203859 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:21203859 | lifeskim:mentions | umls-concept:C0024115 | lld:lifeskim |
| pubmed-article:21203859 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:21203859 | lifeskim:mentions | umls-concept:C0011570 | lld:lifeskim |
| pubmed-article:21203859 | lifeskim:mentions | umls-concept:C0235874 | lld:lifeskim |
| pubmed-article:21203859 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:21203859 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:21203859 | lifeskim:mentions | umls-concept:C1551358 | lld:lifeskim |
| pubmed-article:21203859 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:21203859 | pubmed:dateCreated | 2011-5-13 | lld:pubmed |
| pubmed-article:21203859 | pubmed:abstractText | Little is known about how the development of a new chronic health condition affects management of existing chronic conditions over time. New conditions might worsen management of existing conditions because of competing demands or improve management of existing conditions because of increased engagement with heath care. We assessed the effect of incident stage 0, 1, 2 or 3 breast, colon or prostate cancer; incident depression; or an exacerbation of chronic pulmonary disease on control of type 2 diabetes (DM2). | lld:pubmed |
| pubmed-article:21203859 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21203859 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21203859 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21203859 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21203859 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21203859 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21203859 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:21203859 | pubmed:issn | 1525-1497 | lld:pubmed |
| pubmed-article:21203859 | pubmed:author | pubmed-author:SteinerJohn... | lld:pubmed |
| pubmed-article:21203859 | pubmed:author | pubmed-author:FaircloughDia... | lld:pubmed |
| pubmed-article:21203859 | pubmed:author | pubmed-author:BaylissElizab... | lld:pubmed |
| pubmed-article:21203859 | pubmed:author | pubmed-author:BlatchfordPat... | lld:pubmed |
| pubmed-article:21203859 | pubmed:author | pubmed-author:NewcomerSophi... | lld:pubmed |
| pubmed-article:21203859 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21203859 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:21203859 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21203859 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21203859 | pubmed:pagination | 575-81 | lld:pubmed |
| pubmed-article:21203859 | pubmed:meshHeading | pubmed-meshheading:21203859... | lld:pubmed |
| pubmed-article:21203859 | pubmed:meshHeading | pubmed-meshheading:21203859... | lld:pubmed |
| pubmed-article:21203859 | pubmed:meshHeading | pubmed-meshheading:21203859... | lld:pubmed |
| pubmed-article:21203859 | pubmed:meshHeading | pubmed-meshheading:21203859... | lld:pubmed |
| pubmed-article:21203859 | pubmed:meshHeading | pubmed-meshheading:21203859... | lld:pubmed |
| pubmed-article:21203859 | pubmed:meshHeading | pubmed-meshheading:21203859... | lld:pubmed |
| pubmed-article:21203859 | pubmed:meshHeading | pubmed-meshheading:21203859... | lld:pubmed |
| pubmed-article:21203859 | pubmed:meshHeading | pubmed-meshheading:21203859... | lld:pubmed |
| pubmed-article:21203859 | pubmed:meshHeading | pubmed-meshheading:21203859... | lld:pubmed |
| pubmed-article:21203859 | pubmed:meshHeading | pubmed-meshheading:21203859... | lld:pubmed |
| pubmed-article:21203859 | pubmed:meshHeading | pubmed-meshheading:21203859... | lld:pubmed |
| pubmed-article:21203859 | pubmed:meshHeading | pubmed-meshheading:21203859... | lld:pubmed |
| pubmed-article:21203859 | pubmed:meshHeading | pubmed-meshheading:21203859... | lld:pubmed |
| pubmed-article:21203859 | pubmed:meshHeading | pubmed-meshheading:21203859... | lld:pubmed |
| pubmed-article:21203859 | pubmed:meshHeading | pubmed-meshheading:21203859... | lld:pubmed |
| pubmed-article:21203859 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21203859 | pubmed:articleTitle | The effect of incident cancer, depression and pulmonary disease exacerbations on type 2 diabetes control. | lld:pubmed |
| pubmed-article:21203859 | pubmed:affiliation | Kaiser Permanente Colorado, Institute for Health Research, 10065 E. Harvard Ave. Ste 300, Denver, CO 80231, USA. Elizabeth.Bayliss@KP.org | lld:pubmed |
| pubmed-article:21203859 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21203859 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:21203859 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
